Efficacy and Safety of Sublingual Immunotherapy for Allergic Rhinitis Due to House Dust Mites
Clinical trial NCT07475715 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07475715
- Sponsor
- Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-23
- Primary completion
- 2027-06-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.